South San Francisco, CA, United States of America

Ahmar Iqbal

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Genentech, Inc., Novartis Ag. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ahmar Iqbal. Retrieved from https://idiyas.com/inventor/ahmar-iqbal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ahmar Iqbal: Innovator in Allergy Treatment

Introduction

Ahmar Iqbal is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of allergy treatment, particularly through his innovative patent.

Latest Patents

Ahmar Iqbal holds a patent for "Anti-IgE Antibody Therapy for Multiple Food Allergies." This groundbreaking therapy aims to provide relief for individuals suffering from various food allergies, showcasing his commitment to improving health outcomes.

Career Highlights

Throughout his career, Ahmar has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Genentech, Inc. His experience in these organizations has equipped him with the knowledge and skills necessary to drive innovation in allergy treatments.

Collaborations

Ahmar has collaborated with talented individuals such as Ryan Patrick Owen and Robert A. Wood. These partnerships have further enhanced his research and development efforts in the field of allergy therapies.

Conclusion

Ahmar Iqbal's contributions to allergy treatment through his patent and collaborations with leading companies and professionals highlight his role as an innovator in the medical field. His work continues to pave the way for advancements in allergy therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…